Global Preclinical Research Outsourcing Services Market Report 2022: Rising Investment in R&D and Increased Outsourcing of Non-core Functions Driving Growth –

DUBLIN-(BUSINESS WIRE)–The “Preclinical Research Outsourcing Services: Global Markets” report has been added to supply.

This report identifies the global preclinical research outsourcing services market along with all major global preclinical CRO companies. The overall preclinical research outsourcing services market is segmented globally and by geographic region. The service areas provided by preclinical CROs are also wide-ranging.

The outsourcing service providers/CROs market continues to show significant growth, largely due to increased demand for services in clinical trials, including preclinical research. The deployment of orphan drug and precision medicine therapies, preclinical and clinical trials are becoming increasingly complex, driving the demand for sophisticated outsourcing partners with expertise in preclinical services, disease registries, real-world evidence, medical questions and risk-based surveillance. Expanding service offerings and capabilities remains a prevalent strategy among CROs.

Outsourcing preclinical services to the drug discovery and development process offers the pharmaceutical industry a wide range of opportunities to develop and commercialize innovative methods and technologies. Outsourcing is an attractive approach for investigations that are too complex, too expensive and too time-consuming to perform in-house.

In earlier times, outsourcing was seen as a short-term strategy to realize demand. It is now considered a key lever for core competencies to increase efficiency in pharmaceutical research. Outsourcing can have a positive impact on research outcomes as it reduces the costs and time associated with new innovations.

The report includes

  • An up-to-date overview and analysis of the global markets for preclinical research outsourcing services

  • Global market trend analyzes with historical revenue (sales) data from 2019-2021, forecasts to 2022 and CAGR forecasts to 2026.

  • Global Preclinical Research Outsourcing Services Market Size Estimate and Forecast, Forecasted Growth Trends, and Corresponding Market Share Analysis by Functional Services and Geographical Region

  • In-depth information (facts and figures) on market drivers, market restraints and other macroeconomic forces affecting current and future market demand

  • Identifying companies best positioned to meet this demand through their own technologies, mergers and acquisitions, joint ventures and other strategic alliances

  • Regulatory structure for preclinical research studies in the pharmaceutical industry, marketed and planned products, pricing and reimbursement structure and major developments influencing the development of this market

  • Detailed analysis of strengths, weaknesses and opportunities of prominent players operating in the global preclinical research outsourcing services market

  • Insights into recent industry structure, current competitive scenario, increasing R&D investment, current pharma/CRO contracts and company value share analysis based on their segment revenue

There are two ways to export services:

  • Full vertical integration that maximizes operations performed internally.

  • Virtual operations that refer to full outsourcing and where all operations are methodically outsourced to third parties.

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market dynamics

  • Market drivers

    • Increasing investment in research and development

    • Growth in outsourcing of non-core functions

    • CROS Add efficiency

  • Market restrictions

    • Challenges in Outsourcing Preclinical Research

    • Lack of qualified specialists

  • Market opportunities

    • Growing opportunities in the Asia-Pacific region

    • Inorganic strategies

    • Emerging markets

Chapter 4 Impact of Covid-19

Chapter 5 Global Market Overview

  • Overview of the preclinical process

  • Market for the production of drug substances/active pharmaceutical ingredients for drug development

  • Manufacturers

  • Market Assessment of API Manufacturing Outsourcing for Drug Development

  • Formulation and dosage design outsourcing services

  • Companies

  • Formulation Outsourcing Market Overview and Forecasts

  • Development, validation and testing of analytical/bioanalytical methods

  • Development of analytical methods

  • Validation, verification and qualification of analytical methods

  • Development and Validation of an Analytical Method for Testing Market Environment and Assessments

  • Companies/Suppliers

  • Metabolism, pharmacokinetics and toxicology outsourcing

  • Companies/Suppliers

  • Market Assessments: Metabolism, Pharmacokinetics and Toxicology Outsourcing Services

  • Outsourcing services at preclinical stages

  • Cros and outsourcing of preclinical research

  • Contract production

  • Contract research

Chapter 6 Regulatory landscape

Chapter 7 Market Analysis by Functional Service

  • Discovery Services

  • Chemistry

  • Bioassay

  • Toxicology

Chapter 8 Market Analysis by Regions

Chapter 9 Competitive landscape

  • Market share analysis

  • Current Pharma/Cro contracts

  • Mergers and acquisitions

Chapter 10 Market Opportunity Analysis

  • Porter’s Five Forces Analysis

  • Swot analysis

  • Strengths of the Global Preclinical Research Outsourcing Market

  • Challenges within the Global Preclinical Research Outsourcing Market

  • Opportunities in the Global Market for Preclinical Research Outsourcing Services

  • Threats to the Global Preclinical Research Outsourcing Services Market

Chapter 11 Company Profiles

  • Top 11 Cros

  • Charles River Laboratories

  • Eurofins Scientific

  • Evotec

  • Frontage Labs

  • Icon plc

  • Iquia

  • Laboratory Corporation of America Holdings

  • Medpace

  • Sgs Sa

  • Thermo Fisher Scientific Inc.

  • Wuxi Apptec

For more information on this report, visit

Leave a Comment

Your email address will not be published.